Company
Step Pharma
- Biotech
- Founded:
- 2014
- Location:
- Saint-Genis-Pouilly, France
Description
Step Pharma develops oral, selective CTPS1 inhibitors for targeted cancer treatment, advancing the lead candidate dencatistat (STP938) through clinical development for hematologic malignancies, ovarian cancer, and other solid tumours while supporting related translational research.
Step Pharma is located in the Lake Geneva ecosystem.
Related
Cleara BiotechCleara Biotech develops peptide-based therapies that selectively eliminate p53-impaired cancer cells; products include lead development…
Ability PharmaAbility Pharma develops oral targeted anticancer compounds that induce cytotoxic autophagy in cancer cells and advances clinical-stage…
Artios PharmaArtios Pharma develops and advances DNA damage response targeted oncology medicines, including oral ATR and Polθ inhibitors and a DDRi-ADC…
CimCureCimCure develops cancer vaccines using its proprietary iBoost conjugate technology to induce immune responses that target and destroy…
CellCentricCellCentric develops an oral, first-in-class small-molecule p300/CBP inhibitor, inobrodib, and evaluates its safety and efficacy in…
ORCA TherapeuticsORCA Therapeutics develops oncolytic virus immunotherapies for prostate cancer, producing lead candidate ORCA-010 for treatment‑naive…
Faron PharmaceuticalsFaron Pharmaceuticals creates cancer treatments that use patients’ immune systems, with bexmarilimab, an anti-Clever-1 antibody and myeloid…
Betaglue® TherapeuticsBetaglue® Therapeutics develops localized radiotherapeutic platforms delivering radiation directly into solid tumors, producing precision…
ATXA TherapeuticsATXA Therapeutics develops selective small-molecule thromboxane receptor (TP) antagonists, including lead candidate NTP42, to treat…